Dr. David H. Chansolme, MD
Infectious Disease (Infectious Disease Physician)
- Medicare participating
At a glance
- Medical school
- University of Oklahoma College of Medicine (1997)
- Years since graduation
- 29
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 722
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1997Medical school: University of Oklahoma College of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Infectious Disease Physician primary
OK license 23723
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Integris Baptist Medical Center, Inc Oklahoma City, OK
- Norman Regional Norman, OK
- Integris Southwest Medical Center Oklahoma City, OK
- Memorial Health Lawton, OK
- Community Hospital, LLC Oklahoma City, OK
Medical groups
- Chickasaw Nation Division of Health Chickasaw Nation Medical Center (240 clinicians)
- Idcokc PLLC (4 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 722
- Services billed
- 371,417
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Injection, daptomycin, 1 mg | 82,400 | 20 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 852 | 325 |
| Established patient office or other outpatient visit, 30-39 minutes | 479 | 310 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 353 | 130 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 298 | 254 |
| Collection of blood sample from central venous tube | 136 | 34 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 101 | 30 |
| Established patient office or other outpatient visit, 40-54 minutes | 67 | 46 |
| Injection, ertapenem sodium, 500 mg | 53 | 12 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 44 | 39 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Daptomycin | 412 |
| Doxycycline Hyclate Other prescribers in Oklahoma City, OK | 345 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Oklahoma City, OK | 335 |
| Biktarvy (bictegrav/emtricit/tenofov ala) | 251 |
| Vancomycin Hcl | 220 |
| Ciprofloxacin Hcl Other prescribers in Oklahoma City, OK | 180 |
| Ceftriaxone (ceftriaxone sodium) Other prescribers in Oklahoma City, OK | 180 |
| Cefazolin Sodium | 148 |
| Ertapenem (ertapenem sodium) | 116 |
| Fluconazole Other prescribers in Oklahoma City, OK | 104 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 35 payments worth $667 in total to this clinician.
| Insmed, Inc. | $215 |
|---|---|
| Gilead Sciences, Inc. | $167 |
| Paratek Pharmaceuticals, Inc. | $79.95 |
| Shionogi Inc | $75.53 |
| Viiv Healthcare Company | $48.24 |
| La Jolla Pharmaceutical Company | $39.85 |
| Merck Sharp & Dohme LLC | $22.01 |
| AbbVie Inc. | $20.29 |
| Food and Beverage | $667 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.